PPXRD-10 Presentations

May 2011 – Lyon, France

 

Presentation Title Authors
‣ Using XRD to monitor the influence of milling on physical properties of a hydrate Itai Adin, Chemagis Ltd., Israel
‣ In situ Measurement and Characterization of Crystal Growth by X-ray Diffraction – Crystallization Monitoring – a QbD tool – Detlef Beckers, PANalytical B.V., The Netherlands
‣ Stability and Desolvation Kinetics of Droperidol Hydrates and an Ethonal Solvate, Studied by Powder X-ray Diffraction and Differental Thermal Analysis/Termogravimetry Agris Berzins, University of Latvia, Riga, Latvia
‣ Total Scattering Pair Distribution Functions (TSPDF) for Fingerprinting Amorphous Pharmaceuticals Simon Billinge, Columbia University, New York, NY, USA
‣ A Novel Method to Determine Amorphous Phase Concentrations Using the Rietveld Refinement Technique Xim Bokhimi, Institute of Physics, Universidad NacionalAutónomade México (UNAM)
‣ Addressing the challenges in applying crystal structure prediction to pharmaceutical materials Graeme M. Day, Department of Chemistry, University of
Cambridge, Cambridge, UK
‣ Reference Materials for the Study of Polymorphism and Crystallinity of Cellulose Tim Fawcett, ICDD, Newtown Square, PA, USA
‣ Application of Automated Electron Diffraction to Structural Investigation of Molecular Crystals Tatiana Gorelik, Johannes-Gutenberg University Mainz, Mainz, Germany
‣ VÅNTEC-500 Area Detector for Pharmaceutical XRD Bob He, Bruker AXS Inc, Madison, WI, USA
‣ Investigation of Solid-state Stability of a Co-crystal API in Formulation Development by XRPD and ss- NMR Spectroscopy Z. Jane Li, Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA
‣ An Overview of Solid Form Screening During Drug Development Ann Newman, SeventhStreet Development Group, Lafayette, IN, USA
‣ NEW techniques for TEM – nanoanalysis  precession electron diffraction for organic  –  inorganic nanostructures Stavros Nikolopoulos, NanoMEGAS SPRL, Brussels, Belgium
‣ HR-XRPD and Polymorph Stability Ivo B. Rietveld, Universite Paris Descartes, Paris, France
‣ Complementary Crystallography and X-ray Powder Diffraction Methods Greg Stephenson, Lilly Research Laboratories, Eli Lilly and
Company,Indianapolis, IN, USA
‣ Effect of Processing Conditions on the Physical State of Solutes in Lyophilized Formulations Prakash Sundaramurthi, Scientific Affairs, Teva Parenteral
Medicines. Inc., Irvine CA, USA
‣ Polymorphism and Solvates of Flecainide Base Kaspar Veldre, University of Latvia, Riga, Latvia
Scroll to Top